VIROMARKERS at CROI 2026
- 12 minutes ago
- 1 min read
From 22 to 25 February 2026, members of the VIROMARKERS consortium, including University of Rome Tor Vergata, ASST Santi Paolo e Carlo, University of Cologne and MIB GmbH, attended the Conference on Retroviruses and Opportunistic Infections 2026 in Denver.
During the conference, a VIROMARKERS-related study was presented in the lecture “Characterization of mutations outside the integrase in HIV-1 individuals in whom Dolutegravir failed” by Aurélie Minelle Kengni Ngueko from the Centre International de Référence Chantal Biya (Cameroon), during the Noncanonical Mutations Conferring Resistance to InSTIs oral session.
You can explore the conference and the abstract here:
Throughout the meeting, the VIROMARKERS team also followed several presentations of particular interest for the project’s research activities. Among them:
“Defective HIV-1 proviruses express Env and contribute to soluble gp120 in the plasma of PWH on ART”
“Sex-specific differences in HIV replication and inflammation in the rectal explant challenge model”
Participation in CROI 2026 provided an important opportunity for the consortium to engage with the latest developments in HIV research and to exchange insights with the international scientific community.
See you at the next conference!
